NextStep Robotics Featured on MSN: Challenging the Status Quo in Stroke Recovery
We're thrilled to announce that NextStep Robotics was recently featured on MSN (seen here: NSR on MSN), highlighting our groundbreaking work in neurorehabilitation! This article showcases our commitment to improving the lives of individuals affected by neurological conditions, particularly stroke, and we wanted to share the exciting news with you, our valued partners in patient care and those seeking innovative solutions.
The MSN article details how NextStep Robotics was founded on the belief that technology can revolutionize neurorehabilitation. Recognizing the limitations of traditional methods, our team of engineers, clinicians, and researchers set out to create cutting-edge solutions that empower patients to achieve greater independence and mobility. Our journey began with studies at the Baltimore VA, where we saw remarkable results, with up to 85% of participants reducing their reliance on assistive devices. This inspired us to bring our technology out of the lab and into the clinic.
A major focus of the article is our AMBLE device, a lightweight, wearable ankle exoskeleton designed to address foot drop and reduce fall risk – a critical concern for many stroke survivors. The MSN feature highlights the impressive results of a recent clinical trial published in the Journal of Rehabilitation Research and Development. The study demonstrated AMBLE's effectiveness in improving key fall risk factors, including:
- Increased Toe Clearance: A 30% improvement, crucial for preventing trips and falls.
- Enhanced Ankle Dorsiflexion: A 20% increase in velocity, leading to a smoother gait.
- Increased Heel-First Foot Strikes: A shift towards a more natural gait pattern, further reducing fall risks.
- Improved Functional Mobility: Gains in gait speed, dynamic balance, and walking distance.
These findings are game-changing, demonstrating AMBLE's potential to significantly reduce fall risks and improve overall mobility for stroke patients.
But what truly sets NextStep Robotics apart, and what the MSN article emphasizes, is our challenge to the conventional wisdom surrounding stroke recovery. We're defying the long-held belief that significant functional improvements are unlikely beyond six months post-stroke. Our clinical trial data shows substantial gains in gait and balance even in individuals with chronic stroke, some years after their initial event. This is a paradigm shift, offering renewed hope for long-term recovery and improved quality of life.
For physical therapists, this means having access to a powerful new tool in your rehabilitation arsenal. AMBLE allows you to provide your patients with cutting-edge technology that enhances their recovery potential and helps them achieve greater independence.
For patients, this news offers hope and a path towards regaining lost mobility and function, even years after a stroke. NextStep Robotics is committed to developing and delivering innovative solutions that challenge the status quo and empower you to live a fuller life.
Beyond AMBLE, the MSN article also highlights our pipeline of other promising neurorehabilitation devices, including REACH for upper extremity training and a Gait Analysis Tool. We are constantly innovating and pushing the boundaries of what's possible in stroke recovery.
We are incredibly proud to be featured on MSN and recognized for our contributions to the field of neurorehabilitation. We invite you to read the full article and learn more about how NextStep Robotics is leading the way in stroke recovery. We are dedicated to partnering with physical therapists and empowering patients to achieve their full potential. Contact us today to learn more about how we can work together to improve the lives of those affected by stroke.
NextStep Robotics Featured on MSN!